Becker's Healthcare February 22, 2024
The FDA recently approved the first tumor-infiltrating lymphocyte, or TIL, therapy to treat advanced melanoma, and 27 institutions have so far been authorized to deliver the treatment.
Federal regulators approved Amtagvi — made my Iovance Biotherapeutic — Feb. 16 to treat adults with unresectable or metastatic melanoma, which is when the cancer cannot be surgically removed or has spread to other parts of the body. It is the first cell therapy approved to treat solid tumors.
The one-time treatment involves extracting T cells from a patient’s own tumor, multiplying them in a laboratory and reinfusing them into the patient in an “activated” state to attack the cancer.
Below is a list of hospitals that have been authorized...
Today's Sponsors
Today's Sponsor